Risks with continuous subcutaneous insulin infusion can be serious
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7314.693/a (Published 22 September 2001) Cite this as: BMJ 2001;323:693
- G Knight, consultant physician
- Rotherham General Hospitals NHS Trust, Rotherham General Hospital, Rotherham S60 2UD
EDITOR—The editorial by Pickup and Keen about continuous subcutaneous insulin infusion is worrying in advocating this treatment, albeit for a comparatively small proportion of the diabetic population in Britain.1 Pickup and Keen do not highlight adequately the serious risks associated with it for doctors considering introducing this treatment to their patients.
Pickup and Keen acknowledge high rates of ketoacidosis with subcutaneous insulin infusion but attribute it to lack of experience, unsuitable pump insulin, and the less reliable devices previously available. They …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.